Sort
39,280 grants matching “leukemia”
Genetic characterization of osteoblast-induced leukemias
$461,485Stavroula Kousteni · Columbia University Health Sciences · R01 · FY2019 · HL
Targeting AML with PI3K/AKT inhibitors and BH3-mimetics
$461,477Steven Grant · Virginia Commonwealth University · R01 · FY2015 · CA
Metabolic Regulation in Leukemia-Initatiating Cells
$461,462Daisuke Nakada · Baylor College Of Medicine · R01 · FY2015 · CA
Enhancement of MS signal processing toward improved cancer biomarker discovery
$461,201Dariya I. Malyarenko · College Of William And Mary · R01 · FY2008 · CA
SRC FAMILY KINASES AND CELL GROWTH REGULATION
$461,197Fred Hutchinson Cancer Research Center · R37 · FY2003 · CA
Mechanisms of Homeodomain Transcriptional Specificity
$461,157Brian Gebelein · Cincinnati Childrens Hosp Med Ctr · R01 · FY2020 · GM
Clinical Transplantation Exploiting NK Cell Activity
$461,157Daniel J Weisdorf · University Of Minnesota · P01 · FY2013 · CA
Doxorubicin Cardiomyopathy: Molecular Genetics & Rescue
$461,096Laurence H Kedes · University Of Southern California · R01 · FY2006 · HL
The role of JADE in HBO complexes
$461,092Tatiana G Kutateladze · University Of Colorado Denver · R01 · FY2021 · HL
The role of JADE in HBO complexes
$461,092Tatiana G Kutateladze · University Of Colorado Denver · R01 · FY2020 · HL
The role of JADE in HBO complexes
$461,092Tatiana G Kutateladze · University Of Colorado Denver · R01 · FY2022 · HL
The role of JADE in HBO complexes
$461,092Tatiana G Kutateladze · University Of Colorado Denver · R01 · FY2023 · HL
Drug resistant pathways in relapsed acute lymphoblastic leukemia (ALL)
$461,060William L. Carroll · New York University School Of Medicine · R01 · FY2018 · CA
ROS-targeted therapy for pancreatic cancer
$460,974Nouri Neamati · University Of Michigan At Ann Arbor · R01 · FY2016 · CA
ROS-targeted therapy for pancreatic cancer
$460,974Nouri Neamati · University Of Michigan At Ann Arbor · R01 · FY2015 · CA
DOXORUBICIN CARDIOMYOPATHY: MOLECULAR GENETICS &RESCUE
$460,890University Of Southern California · R01 · FY2001 · HL
Anticancer Agent Pharmacodynamics in Acute Leukemia
$460,757St. Jude Children'S Research Hospital · R01 · FY2002 · CA
Molecular Diagnosis and Prognosis in Aggressive Lymphoma
$460,703Lisa Rimsza · University Of Arizona · U01 · FY2013 · CA
Ph1/2 Study of the Imipridone ONC201 for Treatment of AML IND125,203 (12/23/2014)
$460,702Michael W Andreeff · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · FD
Metabolic control of normal and malignant hematopoiesis
$460,563Andrew Michael Intlekofer · Sloan-Kettering Inst Can Research · R37 · FY2024 · CA
TRANSCRIPTIONAL REGULATION OF ANTIBODY RESPONSES AND IMMUNITY
$460,500Deepta Bhattacharya · University Of Arizona · R01 · FY2022 · AI
Prevention of Platelet Alloimmunization by Costimulatory Blockade
$460,487James C. Zimring · Bloodworks · R01 · FY2015 · HL
Controlling an Ontogenic Masterswitch to Maximize Thrombopoiesis
$460,426Adam N. Goldfarb · University Of Virginia · R01 · FY2015 · HL
Structure, Function, and Mechanism of a Mitochondrial Chaperone
$460,421Francis T.f. Tsai · Baylor College Of Medicine · R01 · FY2024 · GM
Structure, Function, and Mechanism of a Mitochondrial Chaperone
$460,421Francis T.f. Tsai · Baylor College Of Medicine · R01 · FY2023 · GM